导电系统节奏与心脏再同步治疗的常规双节奏:我们正朝着什么方向前进?
Giulia Domenichini1, Mathieu Le Bloa1, Cheryl Teres Castillo1
1Cardiology Service, University Hospital of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Journal of clinical medicine
|October 14, 2023
概括
导电系统节奏 (CSP) 为心力衰竭患者提供生理心室激活,这些患者需要心脏再同步治疗 (CRT). 虽然有希望,但需要进一步的大型研究来证实其长期疗效和用于常规临床使用的性能.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 导电系统节奏 (CSP) 是一种新的节奏策略,提供生理性心室激活,超过了常规的右心室节奏.
- CSP正在成为心力衰竭患者的心脏再同步疗法 (CRT) 的双心室节奏替代品.
- 目前的临床数据表明CSP的CRT潜力,但大型随机试验不足以确定其常规使用.
研究的目的:
- 审查当前传导系统节奏 (CSP) 的最新状态,作为心力衰竭中CRT的双心室节奏的替代方案.
- 讨论支持CRT的CSP的生理原理.
- 探索CRT中CSP的未来前景,考虑植入技术和现有的临床数据.
主要方法:
- 对心脏再同步疗法 (CRT) 传导系统节奏 (CSP) 现有文献的审查.
- 对支持心力衰竭中CSP的生理概念的分析.
- 讨论植入技术,包括他的捆绑节奏和左捆绑分支区域节奏.
- 对CRT的CSP发表的临床数据的评估.
主要成果:
- 与传统的节拍方法相比,CSP提供了更多的生理心室激活.
- 初步数据表明,CSP是CRT的可行替代品,尽管长期结果需要进一步调查.
- 需要解决对CSP的长期性能和提取能力的担忧.
结论:
- 导电系统节奏 (CSP) 是心力衰竭患者心脏再同步治疗 (CRT) 的有希望的生理方法.
- 来自大型随机试验的进一步强有力的临床证据对于验证CSP的有效性和安全性至关重要,以便广泛采用.
- 对植入技术和领先技术的持续研究将塑造CRT中CSP的未来.
相关概念视频
Conduction System of the Heart
8.0K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
8.0K
Electrophysiology of Normal Cardiac Rhythm
5.4K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
5.4K
Pulse rhythm
815
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
815
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Dysrhythmias IV: Characteristics of Bradyarrhythmias
10
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
10
Cardiopulmonary Resuscitation IV: Pharmacological Management
12
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
12


